Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/15/2002US6465447 Solvent extraction, concentration and chromatographic purification of active fraction of fruit body of tochukaso; 3,5,6-trihydroxy-10,13,14-trimethyl-11-acetoxy-17-(2-(5,6-dimethyl-hept-3 -ene))gonane-3-one
10/15/2002US6465446 Side effect reduction; does not appreciably stimulate, increase or otherwise enhance production of sex hormones
10/15/2002US6465445 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
10/15/2002US6465444 Protein tyrosine phosphatases(ptp-1b); antidiabetic, antitumor and anorexigenic agents; combination therapy
10/15/2002US6465443 Method for inhibiting bone resorption
10/15/2002US6465442 Without delivery into systemic circulation or to central nervous system
10/15/2002US6465441 Screening method for modulation of human mast cell activation
10/15/2002US6465440 Antimutagenic compositions for treatment and prevention of photodamage to skin
10/15/2002US6465438 Nucleic acid vaccination for parvoviral infections
10/15/2002US6465437 Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
10/15/2002US6465436 Method for treating alcohol intoxication and alcohol abuse
10/15/2002US6465435 Prevention and/or treatment of antibiotic associated diarrhea or pseudomembranous colitis; binding and eliminating toxins a and b from gastrointestinal tract using oligosaccharide sequence attached to inert support by nonpetidyl linker
10/15/2002US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002US6465428 Synergistic combination for treatment of multi-drug resistant staphylococci especially methicillin-resistant staphylococci
10/15/2002US6465421 Promoting the growth of body and/or head hair and/or combatting the loss of such hair via cyclooxygenase treatment, as well as, contrariwise, retarding and/or preventing the growth of body/cranial hair via lipoxygenase treatment
10/15/2002US6465258 Farnesoid x receptor (fxr) functions as a bile acid receptor/sensor that mediates cyp7 expression in a bile-acid dependent manner; drug screening for anticholesterol agents
10/15/2002US6465187 Inhibition of gene expression of antiapoptotic genes to treat mast cell mediated inflammatory disorders
10/15/2002US6465021 Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease
10/15/2002US6465020 Use of garlic extract as both preventive and therapeutic agents for human prostate and bladder cancers
10/15/2002US6465013 Folic acid in solid dosage forms
10/15/2002US6465012 Tablet form with more than 76% by weight of gabapentin; made by spray coating with binder solution and compressing into non-friable tablets; improved compressibility, compactibility
10/15/2002US6465011 Formulations comprising lipid-regulating agents
10/15/2002US6465008 For therapy of tumors
10/15/2002US6465006 Using controlled heat and other physical means to improve dermal, mucosal, and injection administration of drugs; heating patch with iron powder for exothermic reaction
10/15/2002US6465005 Steroid as a crystallization inhibitor during storage; inhibitor selected from an estrogen, a progestogen, an androgen and a glucocorticoid
10/15/2002US6464994 Diaper dermatitis preventative medication and a method for making and using same
10/15/2002US6464992 Topical micronutrient delivery system and uses thereof
10/15/2002US6464990 Nanoemulsion based on ethylene oxide and propylene oxide block copolymers and its uses in the cosmetics, dermatological and/or ophthalmological fields
10/15/2002US6464981 Therapeutic agent for a cancer and method of screening the same, and health-care auxiliary food
10/15/2002US6464971 Anionic or cationic dendrimer antimicrobial or autiprotozoan compositions
10/15/2002US6464970 Method and composition for preventing surgical adhesions
10/15/2002US6464959 Protective colloid stabilizer.
10/15/2002US6464958 Process for the preparation of suspensions of drug particles for inhalation delivery
10/15/2002US6464661 Medical probe with stylets
10/15/2002US6463933 Bone marrow as a site for transplantation
10/15/2002CA2337750C Therapeutic or cosmetic compositions containing dimeric or polymeric forms of hydroxyacids, and their therapeutic use
10/15/2002CA2310926C A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease
10/15/2002CA2277801C Preparation of particles for inhalation
10/15/2002CA2256438C Aromatic amidine derivatives useful as selective thrombin inhibitors
10/15/2002CA2253795C Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
10/15/2002CA2191837C Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
10/15/2002CA2145211C The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
10/15/2002CA2112690C Amino acid derivative
10/15/2002CA2091766C Enhancement of glutathione levels with glutamine
10/15/2002CA2067274C Solvates of dirithromycin and a process for isolating form ii dirithromycin
10/15/2002CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/15/2002CA2063521C Tacky, hydrophilic gel dressings and products therefrom
10/15/2002CA2062412C Lowering blood cholesterol levels using water soluble cellulose ethers
10/15/2002CA2043253C Cyclodextrin complex
10/15/2002CA2038985C Haloethyl-substituted steroidal enzyme inhibitors
10/15/2002CA1341393C Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
10/12/2002CA2343949A1 Benazepril hydrochloride tablet formulations
10/11/2002CA2357110A1 Method for the treatment of polycystic kidney disease
10/10/2002WO2003084997A1 Probes, systems and methods for drug discovery
10/10/2002WO2002079778A2 In vivo delivery methods and compositions
10/10/2002WO2002079517A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002WO2002079478A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders
10/10/2002WO2002079465A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
10/10/2002WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002WO2002079299A1 Agent for the prevention and treatment of sexually transmitted diseases-i
10/10/2002WO2002079266A1 Food product with prolonged energy release
10/10/2002WO2002079262A1 Composition for enteral nutrition comprising fibres
10/10/2002WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002WO2002079243A2 Gonococcal proteins and nucleic acids
10/10/2002WO2002079221A2 Sapogenin derivatives, their synthesis and use
10/10/2002WO2002079220A2 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
10/10/2002WO2002079203A1 Imidazo-triazine derivatives as pde 5 inhibitors
10/10/2002WO2002079200A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
10/10/2002WO2002079199A1 Thiophene derivatives and use thereof
10/10/2002WO2002079198A1 Pyridazinone aldose reductase inhibitors
10/10/2002WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002WO2002079196A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/10/2002WO2002079195A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
10/10/2002WO2002079194A1 Ccr5 antagonists useful for treating aids
10/10/2002WO2002079193A1 Inhibitors of cyclin dependent kinases as anti-cancer agent
10/10/2002WO2002079192A1 Novel tyrosine kinase inhibitors
10/10/2002WO2002079188A1 Pyrrolidine sulfonamides
10/10/2002WO2002079186A2 Aminopiperidine derivatives as modulators of chemokine receptor activity
10/10/2002WO2002079183A1 Halogenated rhodamine derivatives and applications thereof
10/10/2002WO2002079175A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors
10/10/2002WO2002079170A2 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing them
10/10/2002WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079168A1 Imidazolyl derivatives useful as histamine h3 receptor ligands
10/10/2002WO2002079167A1 Geldanamycin derivative and method of treating cancer using same
10/10/2002WO2002079165A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof
10/10/2002WO2002079164A1 Quinoline derivatives and their use as antibiotics
10/10/2002WO2002079163A1 Aminopyridine derivatives as estrogen receptor modulators
10/10/2002WO2002079158A1 Novel amlodipine camsylate and method for preparing thereof
10/10/2002WO2002079157A1 Aryl oxime-piperazines useful as ccr5 antagonists
10/10/2002WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002WO2002079155A1 Pyrrolidine sulfonamides
10/10/2002WO2002079154A1 Substituted carbazoles as inhibitors of spla2
10/10/2002WO2002079152A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002WO2002079149A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002WO2002079139A1 Conjugated unsaturated glyceride mixtures and a method for producing the same
10/10/2002WO2002078863A1 Generation of pharmaceutical agent particles using focused acoustic energy
10/10/2002WO2002078747A2 Pregabalin lactose conjugates
10/10/2002WO2002078745A2 Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia
1 ... 5682 5683 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 5702 ... 7860